Cardinal Health Past Earnings Performance
Past criteria checks 2/6
Cardinal Health has been growing earnings at an average annual rate of 25.5%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 8.6% per year.
Key information
25.5%
Earnings growth rate
25.2%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 8.6% |
| Return on equity | n/a |
| Net Margin | 0.3% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14
Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Sep 29Cardinal Health: Aristocrat Heading For A Makeover
Sep 26PayrHealth to collaborate with Cardinal Health
Sep 15Cardinal Health in pact with activist investor Elliot for value creation measures
Sep 06Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957
Sep 01Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley
Aug 16Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?
Aug 15Cardinal Health Q4 2022 Earnings Preview
Aug 10Cardinal Health appoints Michelle Greene as CIO
Aug 01Cardinal Health: Little Price Appreciation Potential But Covered Calls Are Worth Considering
Jul 22Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Cardinal Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 216,148 | 639 | 4,926 | 0 |
| 30 Sep 23 | 210,172 | 156 | 4,834 | 0 |
| 30 Jun 23 | 205,012 | 261 | 4,834 | 0 |
| 31 Mar 23 | 198,662 | 463 | 4,722 | 0 |
| 31 Dec 22 | 193,011 | -1,273 | 4,680 | 0 |
| 30 Sep 22 | 186,999 | -1,094 | 4,640 | 0 |
| 30 Jun 22 | 181,364 | -933 | 4,557 | 0 |
| 31 Mar 22 | 176,847 | -955 | 4,531 | 0 |
| 31 Dec 21 | 171,286 | 555 | 4,514 | 0 |
| 30 Sep 21 | 167,370 | 1,135 | 4,510 | 0 |
| 30 Jun 21 | 162,467 | 611 | 4,533 | 0 |
| 31 Mar 21 | 156,570 | 1,151 | 4,541 | 0 |
| 31 Dec 20 | 156,452 | 1,382 | 4,586 | 0 |
| 30 Sep 20 | 154,646 | 973 | 4,602 | 0 |
| 30 Jun 20 | 152,922 | -3,696 | 4,572 | 0 |
| 31 Mar 20 | 153,586 | -4,158 | 4,600 | 0 |
| 31 Dec 19 | 149,657 | -4,212 | 4,531 | 0 |
| 30 Sep 19 | 147,662 | -4,152 | 4,432 | 0 |
| 30 Jun 19 | 145,534 | 1,363 | 4,480 | 0 |
| 31 Mar 19 | 143,530 | 3 | 4,586 | 0 |
| 31 Dec 18 | 141,935 | -39 | 4,622 | 0 |
| 30 Sep 18 | 139,381 | 734 | 4,689 | 0 |
| 30 Jun 18 | 136,809 | 256 | 4,596 | 0 |
| 31 Mar 18 | 134,426 | 1,696 | 4,308 | 0 |
| 31 Dec 17 | 132,614 | 1,823 | 4,137 | 0 |
| 30 Sep 17 | 130,578 | 1,094 | 3,917 | 0 |
| 30 Jun 17 | 129,976 | 1,288 | 3,775 | 0 |
| 31 Mar 17 | 128,394 | 1,346 | 3,762 | 0 |
| 31 Dec 16 | 127,236 | 1,351 | 3,715 | 0 |
| 30 Sep 16 | 125,530 | 1,353 | 3,726 | 0 |
| 30 Jun 16 | 121,546 | 1,427 | 3,648 | 0 |
| 31 Mar 16 | 117,710 | 1,387 | 3,525 | 0 |
| 31 Dec 15 | 112,423 | 1,366 | 3,414 | 0 |
| 30 Sep 15 | 106,516 | 1,329 | 3,307 | 0 |
| 30 Jun 15 | 102,531 | 1,212 | 3,240 | 0 |
| 31 Mar 15 | 97,877 | 1,154 | 3,188 | 0 |
| 31 Dec 14 | 93,928 | 1,104 | 3,121 | 0 |
| 30 Sep 14 | 90,631 | 1,089 | 3,071 | 0 |
| 30 Jun 14 | 91,084 | 1,163 | 3,028 | 0 |
| 31 Mar 14 | 93,610 | 343 | 3,009 | 0 |
| 31 Dec 13 | 96,735 | 374 | 2,984 | 0 |
| 30 Sep 13 | 99,727 | 403 | 2,917 | 0 |
| 30 Jun 13 | 101,093 | 335 | 2,875 | 0 |
Quality Earnings: CAH has a large one-off loss of $853.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: CAH became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CAH has become profitable over the past 5 years, growing earnings by 25.5% per year.
Accelerating Growth: CAH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CAH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (7.1%).
Return on Equity
High ROE: CAH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.